A head-to-head comparison by Kuten et al. [13] showed that both [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 identified all lesions in the prostate in intermediate- or high-risk prostate cancer patients at staging. This evidence concerns the gene FOLH1 and Familial prostate cancer.